BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8212320)

  • 1. Investigation of vascular mechanisms: bridging the gap between basic research and clinical trials.
    Collier J; Vallance P
    Trends Pharmacol Sci; 1993 Jul; 14(7):257-8. PubMed ID: 8212320
    [No Abstract]   [Full Text] [Related]  

  • 2. Abstracts of the 11th International Congress on Cardiovascular Pharmacotherapy. Montreal, Canada, 18-21 May 2002.
    Cardiovasc Drugs Ther; 2002; 16 Suppl 1():5-116. PubMed ID: 12108434
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the 13th International Congress on Cardiovascular Pharmacotherapy. November 29-December 2, 2007. Antalya, Turkey.
    Remme WJ
    Cardiovasc Drugs Ther; 2007 Nov; 21 Suppl 1(1):S6-43. PubMed ID: 17963033
    [No Abstract]   [Full Text] [Related]  

  • 4. The importance of drug discovery for treatment of cardiovascular diseases.
    Kennedy C
    Future Med Chem; 2013 Mar; 5(4):355-7. PubMed ID: 23495678
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of sex on cardiovascular drug responses: role of estrogen.
    Abdel-Rahman AA
    Curr Opin Pharmacol; 2017 Apr; 33():1-5. PubMed ID: 28340373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial fat: a new cardiovascular therapeutic target.
    Iacobellis G
    Curr Opin Pharmacol; 2016 Apr; 27():13-8. PubMed ID: 26848943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of phenotypic high-throughput screening techniques to cardiovascular research.
    Etzion Y; Muslin AJ
    Trends Cardiovasc Med; 2009 Aug; 19(6):207-12. PubMed ID: 20211437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiovascular medications on exercise responses.
    Peel C; Mossberg KA
    Phys Ther; 1995 May; 75(5):387-96. PubMed ID: 7732083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular receptors as drug targets. Eur omega Conferences' Cardiovascular receptors as drug targets. Institut Pasteur, Paris, France, 3-4 October 1996.
    Maack T
    Mol Med Today; 1997 Mar; 3(3):101-2. PubMed ID: 9095483
    [No Abstract]   [Full Text] [Related]  

  • 10. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 11. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 2.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):7-9. PubMed ID: 19127495
    [No Abstract]   [Full Text] [Related]  

  • 12. American Heart Association--Scientific Sessions 2008--Studies with investigative drugs--Part 1.
    Kirkham K
    IDrugs; 2009 Jan; 12(1):5-6. PubMed ID: 19127494
    [No Abstract]   [Full Text] [Related]  

  • 13. Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
    Rosano GM; Lewis B; Agewall S; Wassmann S; Vitale C; Schmidt H; Drexel H; Patak A; Torp-Pedersen C; Kjeldsen KP; Tamargo J
    Eur Heart J; 2015 Oct; 36(40):2677-80. PubMed ID: 25948737
    [No Abstract]   [Full Text] [Related]  

  • 14. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular-Active Venom Toxins: An Overview.
    Rebello Horta CC; Chatzaki M; Rezende BA; Magalhães Bde F; Duarte CG; Felicori LF; Ribeiro Oliveira-Mendes BB; do Carmo AO; Chávez-Olórtegui C; Kalapothakis E
    Curr Med Chem; 2016; 23(6):603-22. PubMed ID: 26812904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added benefits of nifedipine (Adalat GITS) beyond lowering blood pressure.
    Cardiovasc J S Afr; 2004; 15(4):198-9. PubMed ID: 15322581
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cardiovascular pharmacology (V). Pharmacological interactions in the patient on immunodepressant treatment].
    Alonso Pulpón L; Anguita Sánchez M
    Rev Esp Cardiol; 1994 Oct; 47(10):687-98. PubMed ID: 7991923
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiovascular drug therapy in elderly patients: specific age-related pharmacokinetic, pharmacodynamic and therapeutic considerations.
    Mangoni AA
    Drugs Aging; 2005; 22(11):913-41. PubMed ID: 16323970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular calcification--a new window on the cardiovascular system: role of agents used to manipulate skeletal integrity.
    Covic A; Gusbeth-Tatomir P; Goldsmith DJ
    Semin Dial; 2007; 20(2):158-69. PubMed ID: 17374091
    [No Abstract]   [Full Text] [Related]  

  • 20. Autophagy in cardiovascular biology.
    Lavandero S; Chiong M; Rothermel BA; Hill JA
    J Clin Invest; 2015 Jan; 125(1):55-64. PubMed ID: 25654551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.